Vermillion, Inc. (VRML) financial statements (2021 and earlier)

Company profile

Business Address 12117 BEE CAVES ROAD BUILDING THREE
AUSTIN, TX 78738
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments   651923
Cash and cash equivalents   651923
Receivables1110000
Inventory, net of allowances, customer advances and progress billings000000 
Inventory000000 
Other undisclosed current assets1812100011
Total current assets:191311661924
Noncurrent Assets
Operating lease, right-of-use asset0 
Property, plant and equipment1011221
Other noncurrent assets0000   
Other undisclosed noncurrent assets     0 
Total noncurrent assets:1011221
TOTAL ASSETS:201411782124
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5432233
Accounts payable1111111
Accrued liabilities4322122
Taxes payable      0
Debt20000 1
Deferred revenue and credits   0
Other liabilities 0 000 
Other undisclosed current liabilities0     (0)
Total current liabilities:6433335
Noncurrent Liabilities
Long-term debt and lease obligation311120 
Long-term debt, excluding current maturities31112  
Capital lease obligations   0 
Operating lease, liability0 
Liabilities, other than long-term debt 0  0  
Other liabilities 0  0  
Other undisclosed noncurrent liabilities(0)      
Total noncurrent liabilities:311120 
Total liabilities:10544435
Stockholders' equity
Stockholders' equity attributable to parent1097341819
Common stock0000000
Additional paid in capital450431414399389388371
Accumulated deficit(440)(422)(407)(396)(386)(371)(351)
Total stockholders' equity:1097341819
TOTAL LIABILITIES AND EQUITY:201411782124

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues5533323
Revenue, net3323
Cost of revenue
(Cost of Goods and Services Sold)
(3)(3)(3)(3)(3)(2)(1)
Gross profit:11(0)0(0)(0)1
Operating expenses(19)(16)(11)(11)(15)(19)(21)
Operating loss:(18)(15)(11)(10)(15)(19)(19)
Nonoperating income (expense)0(0)(0)(0)00(0)
Investment income, nonoperating     0 
Other nonoperating income (expense)0(0)(0)(0)   
Interest and debt expense     0 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes36    (0)0
Net income (loss):18(15)(11)(10)(15)(19)(19)
Other undisclosed net income (loss) attributable to parent(36)0(0)(0)(0)  
Net loss attributable to parent:(18)(15)(11)(10)(15)(19)(19)
Undistributed earnings (loss) allocated to participating securities, basic   (1)
Net loss available to common stockholders, diluted:(18)(15)(11)(11)(15)(19)(19)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):18(15)(11)(10)(15)(19)(19)
Comprehensive income (loss), net of tax, attributable to parent:18(15)(11)(10)(15)(19)(19)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: